معرفی
Arsène Zongo serves as an Associate Professor at Laval University's Faculty of Pharmacy, specializing in pharmacoepidemiology and real-world evidence generation for drug safety and efficacy assessment. His work bridges clinical pharmacy and population health research with a focus on chronic disease management.
His academic credentials include:
- Undergraduate Doctorate in Pharmacy (Pharm.D) from University of Ouagadougou, Burkina Faso (2001-2008)
- Master's degree in Pharmaceutical Sciences-Pharmacoepidemiology from Laval University (2011-2014)
- Doctorate in Pharmaceutical Sciences-Pharmacoepidemiology from Laval University (2012-2016, accelerated)
- Certificate in Systems Thinking in Public Health from Johns-Hopkins University (2016)
- Certificate in Methods and Practices in Epidemiology from University of Bordeaux 2 (2010-2011)
Zongo's research employs advanced epidemiological and statistical methodologies to analyze large administrative health databases, investigating critical issues in chronic disease treatment including diabetes medication safety (particularly SGLT2 inhibitors), medical cannabis efficacy, treatment adherence patterns, and health outcomes such as morbidity and mortality. His work directly impacts pharmaceutical policy and clinical practice through real-world evidence generation.
His distinguished recognition includes:
- Mitacs Accelerate Fellowship (2018)
- Financial Scholarship for Excellence in Pharmacoepidemiology Research (2015)
- Leadership and Sustainable Development Scholarship (2011)
- Chair on Treatment Adherence Scholarship (2011-2015)
- SIDACTION Epidemiology Certificate Scholarship (2010-2011)
- Burkina Faso Government Pharmacy Scholarship (2001-2008)
Zongo actively shapes pharmaceutical education as course co-responsible for PHA-3011 (Scientific References), PHA-7014 (Pharmacoepidemiology Concepts), PHA-7015 (Pharmacoepidemiology Project), and PHA-8002 (Advanced Pharmacoepidemiology). His postdoctoral training at the University of Alberta's School of Public Health with the Alliance for Canadian Health Outcomes Research in Diabetes (2017-2018) further strengthened his expertise in health outcomes research.
